Literature DB >> 1327326

Neuromyotonia: report of a case.

B Kukowski1, M Feldmann.   

Abstract

Neuromyotonia is a rare condition of peripheral nerve dysfunction characterized by the signs of motor nerve hyperactivity, namely, myokymia, fasciculations, and muscular stiffness. Relaxation of voluntary muscle contraction is delayed, and fluid movements are impaired to a variable degree. Signs of sensory involvement are less frequent. Usually, therapy with carbamazepine or phenytoin provides rapid improvement. In the present communication, a typical case is reported, and the most important differential diagnoses are outlined.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1327326     DOI: 10.1007/bf00210235

Source DB:  PubMed          Journal:  Clin Investig        ISSN: 0941-0198


  15 in total

1.  "Pseudospasticity" in Guillain-Barré syndrome.

Authors:  D C Preston; J J Kelly
Journal:  Neurology       Date:  1991-01       Impact factor: 9.910

2.  A SYNDROME OF CONTINUOUS MUSCLE-FIBRE ACTIVITY.

Authors:  H Isaacs
Journal:  J Neurol Neurosurg Psychiatry       Date:  1961-11       Impact factor: 10.154

3.  The syndrome of continuous muscle fibre activity: light and electron microscopic studies in muscle and nerve biopsies.

Authors:  S Ono; S Munakata; K Nagao; N Shimizu; N Shimizu
Journal:  J Neurol       Date:  1989-10       Impact factor: 4.849

4.  Generalized muscular stiffness, fasciculations, and myokymia of peripheral nerve origin.

Authors:  W E Wallis; A Van Poznak; F Plum
Journal:  Arch Neurol       Date:  1970-05

5.  [Neuromyotonia].

Authors:  H G Mertens; S Zschocke
Journal:  Klin Wochenschr       Date:  1965-09-01

6.  Electromyographic and nerve conduction findings in a patient with neuromyotonia, normocalcemic tetany and small-cell lung cancer.

Authors:  V S Partanen; H Soininen; M Saksa; P Riekkinen
Journal:  Acta Neurol Scand       Date:  1980-04       Impact factor: 3.209

7.  Syndrome of continuous muscle-fiber activity: increased CSF GABA and effect of dantrolene.

Authors:  T Sakai; S Hosokawa; H Shibasaki; I Goto; Y Kuroiwa; H Sonoda; Y Murai
Journal:  Neurology       Date:  1983-04       Impact factor: 9.910

Review 8.  [Carbamazepine-sensitive neuromyotonia and Charcot-Marie-Tooth disease of the neuronal type].

Authors:  G Serratrice; J Pouget; J F Pellissier; D Cros
Journal:  Rev Neurol (Paris)       Date:  1989       Impact factor: 2.607

9.  Myokymia and impaired muscular relaxation with continuous motor unit activity.

Authors:  F D Lublin; P Tsairis; L J Streletz; R A Chambers; W F Riker; A Van Poznak; S W Duckett
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-06       Impact factor: 10.154

10.  Neurogenic benign fasciculations, pseudomyotonia, and pseudotetany. A disease in search of a name.

Authors:  C Coërs; N Telerman-Toppet; J Durdu
Journal:  Arch Neurol       Date:  1981-05
View more
  1 in total

Review 1.  Neuromyotonia as an unusual neurological complication of primary Sjögren's syndrome: case report and literature review.

Authors:  Fei Xiao
Journal:  Clin Rheumatol       Date:  2016-12-12       Impact factor: 3.650

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.